Skip to main content
logo
Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
15.98
+0.27 (1.72%)
Sep 25, 2026, 4:00 PM EDT - Market closed

Sutro Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
26599152261464689
Market Cap Growth
256.62%-35.03%-41.98%-43.69%-32.55%-30.31%
Enterprise Value
111-51-212-55193453
Last Close Price
15.9811.5718.4042.9080.80148.80

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
5.800.962.441.706.8511.13
PB Ratio
--0.743.401.752.142.73
P/TBV Ratio
--3.401.752.142.73
P/OCF Ratio
----130.85-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
2.44---2.857.32

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.10-0.120.520.230.230.23
Net Debt / Equity Ratio
1.490.95-6.59-2.28-1.31-0.83
Net Debt / EBITDA Ratio
1.221.291.274.152.302.24
Net Debt / FCF Ratio
1.060.701.512.9565.892.16
Asset Turnover
0.200.370.140.350.180.17
Quick Ratio
3.221.942.474.395.135.04
Current Ratio
3.322.012.604.505.315.24
Return on Equity (ROE)
---234.19%-58.25%-50.77%-36.10%
Return on Assets (ROA)
-36.08%-23.38%-34.74%-12.72%-21.54%-16.74%
Return on Capital Employed (ROCE)
-93.10%-106.30%-93.40%-23.70%-37.90%-32.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-68.17%-193.86%-149.92%-40.84%-25.67%-15.33%
FCF Yield
-54.96%-181.52%-128.28%-44.34%-0.93%-14.09%
Buyback Yield / Dilution
-38.81%-9.84%-28.59%-18.57%-10.02%-41.59%
SEC Filings: 10-K · 10-Q